Prof. Dr. Ludwig Plasswilm
Chefarzt/Chefärztin
Radio-Onkologie · Dept. IV
Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
Hundsberger T, Brügge D, Putora P, Weder P, Weber J, Plasswilm L. Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas. J Neurooncol 2013; 112:133-9.
12.01.2013Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
12.01.2013J Neurooncol 2013; 112:133-9
Hundsberger Thomas, Brügge Detlef, Putora Paul Martin, Weder Patrik, Weber Johannes, Plasswilm Ludwig
Re-implantation after insufficient primary 125-I permanent prostate brachytherapy
Putora P, Plasswilm L, Seelentag W, Schiefer J, Markart P, Schmid H, Engeler D. Re-implantation after insufficient primary 125-I permanent prostate brachytherapy. Radiat Oncol 2013; 8:194.
01.01.2013Re-implantation after insufficient primary 125-I permanent prostate brachytherapy
01.01.2013Radiat Oncol 2013; 8:194
Putora Paul Martin, Plasswilm Ludwig, Seelentag Wolf, Schiefer Johann, Markart Patrick, Schmid Hans-Peter, Engeler Daniel
Seed Migration nach LDR-Brachytherapie der Prostata mit J-125 Permanentimplantation
Abt D, Markart P, Schwab C, Engeler D, Schiefer J, Plasswilm L, Schmid H (2013). Seed Migration nach LDR-Brachytherapie der Prostata mit J-125 Permanentimplantation.
01.01.2013Seed Migration nach LDR-Brachytherapie der Prostata mit J-125 Permanentimplantation
01.01.2013-
Abt Dominik, Markart Patrick, Schwab Christoph, Engeler Daniel, Schiefer Johann, Plasswilm Ludwig, Schmid Hans-Peter
Bounce-Phänomen als prognostisch günstiger Faktor nach LDR-Brachytherapie - prospektive Auswertung des schweizerischen Registers
Schwab C, Schmid H, Plasswilm L, Engeler D. Bounce-Phänomen als prognostisch günstiger Faktor nach LDR-Brachytherapie - prospektive Auswertung des schweizerischen Registers. Urologe 2013; 52 (suppl 1):101.
01.01.2013Bounce-Phänomen als prognostisch günstiger Faktor nach LDR-Brachytherapie - prospektive Auswertung des schweizerischen Registers
01.01.2013Urologe 2013; 52 (suppl 1):101
Schwab Christoph, Schmid Hans-Peter, Plasswilm Ludwig, Engeler Daniel
Compensability index for compensation radiotherapy after treatment interruptions
Putora P, Schmücking M, Aebersold D, Plasswilm L. Compensability index for compensation radiotherapy after treatment interruptions. Radiation Oncology 2012; 2012:208.
08.12.2012Compensability index for compensation radiotherapy after treatment interruptions
08.12.2012Radiation Oncology 2012; 2012:208
Putora Paul Martin, Schmücking Michael, Aebersold D, Plasswilm Ludwig
Compensability index for compensation radiotherapy after treatment interruptions
Putora P, Schmuecking M, Aebersold D, Plasswilm L. Compensability index for compensation radiotherapy after treatment interruptions. Radiat Oncol 2012; 7:208.
08.12.2012Compensability index for compensation radiotherapy after treatment interruptions
08.12.2012Radiat Oncol 2012; 7:208
Putora Paul Martin, Schmuecking Michael, Aebersold Daniel, Plasswilm Ludwig
Surface dose optimization of the Varian Ir-192 HDR surface applicator set
Buchauer K, Schiefer J, Plasswilm L (2012). Surface dose optimization of the Varian Ir-192 HDR surface applicator set.
15.11.2012Surface dose optimization of the Varian Ir-192 HDR surface applicator set
15.11.201247th SSRMP Annual Scientific Meeting SSRMP 2012
Buchauer Konrad, Schiefer Johann, Plasswilm Ludwig
Post Irradiation Sign of Progress in Anaplastic Ependymoma - A Case Report
Horstkemper R, Brügge D, Müller J, Mock B, Plasswilm L (2012). Post Irradiation Sign of Progress in Anaplastic Ependymoma - A Case Report.
20.04.2012Post Irradiation Sign of Progress in Anaplastic Ependymoma - A Case Report
20.04.2012SASRO 2012
Horstkemper Ruth, Brügge Detlef, Müller Joachim, Mock B, Plasswilm Ludwig
Good Reponse of Palliative Radiotherapy for Very Advanced Metastastic Melanoma
Horstkemper R, Putora P, Toepfer M, Plasswilm L (2012). Good Reponse of Palliative Radiotherapy for Very Advanced Metastastic Melanoma.
19.04.2012Good Reponse of Palliative Radiotherapy for Very Advanced Metastastic Melanoma
19.04.2012-
Horstkemper Ruth, Putora Paul Martin, Toepfer Michael, Plasswilm Ludwig
Spinal Cord Myxopapillary Ependymoma in a 15 Years Old Boy
Naef G, Brügge D, Plasswilm L (2012). Spinal Cord Myxopapillary Ependymoma in a 15 Years Old Boy.
19.04.2012Spinal Cord Myxopapillary Ependymoma in a 15 Years Old Boy
19.04.2012SASRO 2012
Naef Gabriela, Brügge Detlef, Plasswilm Ludwig
Manipulation and Quality Assurance of Guidelines; an Online Implementation of Diagnostic Nodes (Dodes)
Putora P, Horstkemper R, Papachristofilou A, Plasswilm L (2012). Manipulation and Quality Assurance of Guidelines; an Online Implementation of Diagnostic Nodes (Dodes).
19.04.2012Manipulation and Quality Assurance of Guidelines; an Online Implementation of Diagnostic Nodes (Dodes)
19.04.2012SASRO 2012
Putora Paul Martin, Horstkemper Ruth, Papachristofilou A, Plasswilm Ludwig
Radiotherapy with 3Gy for Inflammation due to Heterotopic Ossifications
Putora P, Horstkemper R, Müller J, Plasswilm L (2012). Radiotherapy with 3Gy for Inflammation due to Heterotopic Ossifications.
19.04.2012Radiotherapy with 3Gy for Inflammation due to Heterotopic Ossifications
19.04.2012SASRO 2012
Putora Paul Martin, Horstkemper Ruth, Müller Joachim, Plasswilm Ludwig
Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis
Schallegger K, Brügge D, Hitz F, Hundsberger T, Cathomas R, Plasswilm L (2012). Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis.
19.04.2012Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis
19.04.2012SASRO 2012
Schallegger K, Brügge Detlef, Hitz Felicitas, Hundsberger Thomas, Cathomas R, Plasswilm Ludwig
Dosimetric Validation of Eclipse VMAT Plans for Elekta Units Using a Modified Octavius Verification Technique
Naef G, Schiefer J, Peters S, Orvati C, Plasswilm L (2012). Dosimetric Validation of Eclipse VMAT Plans for Elekta Units Using a Modified Octavius Verification Technique.
19.04.2012Dosimetric Validation of Eclipse VMAT Plans for Elekta Units Using a Modified Octavius Verification Technique
19.04.2012SASRO 2012
Naef Gabriela, Schiefer Johann, Peters Samuel, Orvati C, Plasswilm Ludwig
Customized Lung Phantom for Internal Target Volume Evaluation
Putora P, Fornaro J, Devecka M, Duma M, Plasswilm L (2012). Customized Lung Phantom for Internal Target Volume Evaluation.
19.04.2012Customized Lung Phantom for Internal Target Volume Evaluation
19.04.2012SASRO 2012
Putora Paul Martin, Fornaro Jürgen, Devecka M, Duma MN, Plasswilm Ludwig
Non-Gated F-18 FDG PET/CT For Target Volume Delineation in Stereotactic Body Radiation Therapy (SBRT) in Patients with Malignant Lung Lesions and Clinical Outcome
Klass N, Aebersold D, Krause T, Plasswilm L, Blumstein N, Born E, Cihoric N, Schmidhalter D, Früh M, Malthaner M, Toepfer M, Klaeser B, Schmuecking M (2012). Non-Gated F-18 FDG PET/CT For Target Volume Delineation in Stereotactic Body Radiation Therapy (SBRT) in Patients with Malignant Lung Lesions and Clinical Outcome.
19.04.2012Non-Gated F-18 FDG PET/CT For Target Volume Delineation in Stereotactic Body Radiation Therapy (SBRT) in Patients with Malignant Lung Lesions and Clinical Outcome
19.04.2012SASRO 2012
Klass ND, Aebersold D, Krause T, Plasswilm Ludwig, Blumstein N, Born E, Cihoric N, Schmidhalter D, Früh Martin, Malthaner M, Toepfer Michael, Klaeser B, Schmuecking M
Palliative Radiotherapie beim NSCLC
Putora P, Horstkemper R, Plasswilm L. Palliative Radiotherapie beim NSCLC - Indikationen und Verfahren. Schweizerische Zeitschrift für Onkologie 2012; 1:12-16.
21.02.2012Palliative Radiotherapie beim NSCLC
21.02.2012Schweizerische Zeitschrift für Onkologie 2012; 1:12-16
Putora Paul Martin, Horstkemper Ruth, Plasswilm Ludwig
Castration-resistant prostate cancer : Surgical and radio-oncological therapeutic options
Preusser S, Putora P, Plasswilm L, Schmid H. Castration-resistant prostate cancer : Surgical and radio-oncological therapeutic options. Der Urologe 2012; 51:27-31.
22.01.2012Castration-resistant prostate cancer : Surgical and radio-oncological therapeutic options
22.01.2012Der Urologe 2012; 51:27-31
Preusser Stefan, Putora Paul Martin, Plasswilm Ludwig, Schmid Hans-Peter
Reimplantation nach insuffizienter primärer I-125 LDR-Brachytherapie beim Prostatakarzinom
Engeler D, Putora P, Plasswilm L, Seelentag W, Schiefer J, Schmid H (2011). Reimplantation nach insuffizienter primärer I-125 LDR-Brachytherapie beim Prostatakarzinom.
14.09.2011Reimplantation nach insuffizienter primärer I-125 LDR-Brachytherapie beim Prostatakarzinom
14.09.201163. Kongress der Deutschen Gesellschaft für Urologie e.V.
Engeler Daniel, Putora Paul Martin, Plasswilm Ludwig, Seelentag Wolf, Schiefer Johann, Schmid Hans-Peter
Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience
Früh M, Kacsir B, ess s, Cerny T, Rodriguez R, Plasswilm L. Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience. Strahlenther Onkol 2011; 187:561-7.
27.06.2011Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience
27.06.2011Strahlenther Onkol 2011; 187:561-7
Früh Martin, Kacsir Bela, ess silvia, Cerny Thomas, Rodriguez Regulo, Plasswilm Ludwig